APO-RIVASTIGMINE PATCH 10 rivastigmine 9.5 mg/24 hours transdermal drug delivery system sachet

Země: Austrálie

Jazyk: angličtina

Zdroj: Department of Health (Therapeutic Goods Administration)

Aktivní složka:

rivastigmine, Quantity: 18 mg

Dostupné s:

Arrotex Pharmaceuticals Pty Ltd

INN (Mezinárodní Name):

Rivastigmine

Léková forma:

Drug delivery system, transdermal

Složení:

Excipient Ingredients: acrylates copolymer; ethyl acetate; methylated trimethylated silica; hexane; 2-ethylhexyl acrylate; methyl acrylate; acrylic acid; acrylates/ethylhexyl acrylate copolymer

Podání:

Transdermal

Jednotky v balení:

7 transdermal drug delivery systems, 30 transdermal drug delivery systems

Druh předpisu:

(S4) Prescription Only Medicine

Terapeutické indikace:

APO-RIVASTIGMINE is indicated for the treatment of patients with mild to moderate dementia of the Alzheimer's type.

Přehled produktů:

Visual Identification: Circular 10cm2 transdermal patch, tri-layer adhesive matrix, translucent white backing film labelled with "Rivastigmine 9.5 mg/24 h"; Container Type: Sachet; Container Material: Other composite material; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius

Stav Autorizace:

Licence status A

Datum autorizace:

2016-01-12